Squarepoint’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Squarepoint’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,656	Closed	-$586K	–	3658
2022 Q2	$586K	Buy	10,656 +957	+10%	+$50.2K	﹤0.01%	1919
2022 Q1	$311K	Buy	+9,699	New	+$278K	﹤0.01%	2258
2017 Q2	–	Sell	-708	Closed	-$43K	–	1903
2017 Q1	$43K	Buy	+708	New	+$41.2K	﹤0.01%	1461

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Squarepoint's SRRA Position: Q3 2022 in Review

Squarepoint sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 10,656 shares — an estimated $586K sold.

Squarepoint first reported a position in SRRA in Q1 2017 and held it in 3 quarters. The position peaked at $586K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Squarepoint reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Squarepoint sold 10,656 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $586K.
Squarepoint first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Squarepoint's Sierra Oncology, Inc. Common Stock position peaked at $586K in Q2 2022.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.